Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: Involvement of antioxidant and anti-apoptotic mechanisms-Reference-Cited by-同舟云学术

Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: Involvement of antioxidant and anti-apoptotic mechanisms

Published:2014-07 Issue: Volume:268 Page:150-158
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Ding Lianshu,Zhang Chong,Masood Anbrin,Li Jianxin,Sun Jiao,Nadeem Ahmed,Zhang Han-Ting,O’Donnell James M.,Xu Ying

Funder

National Institute of Health

Science and Technology Development Foundation of Huai’an

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference56 articles.

1. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative;Kessler;World Psychiatry,2007

2. Stress-induced oxidative changes in brain;Madrigal;CNS Neurol Disord Drug Targets,2006

3. Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells;Tell;Curr Pharm Des,2009

4. Uwhangchungsimwon, a traditional herbal medicine, protects brain against oxidative injury via modulation of hypothalamus–pituitary–adrenal (HPA) response in a chronic restraint mice model;Lee;J Ethnopharmacol,2014

5. Exercise ameliorates cognition impairment due to restraint stress-induced oxidative insult and reduced BDNF level;Kwon;Biochem Biophys Res Commun,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

2. Amelioration of pain and anxiety in sleep-deprived rats by intra-amygdala injection of cinnamaldehyde;Sleep Medicine: X;2023-12

3. Phosphodiesterase 2 and Its Isoform a as Therapeutic Targets in the Central Nervous System Disorders;CNS & Neurological Disorders - Drug Targets;2023-09-25

4. Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior;International Journal of Neuropsychopharmacology;2023-05-19

5. Phosphodiesterase inhibitors in psychiatric disorders;Psychopharmacology;2023-04-15